'They have done better and that shows up in their margins, which have improved sequentially,' says Nitin Kumar, Quant Broking.

"Stocks like eClerx or Persistent have that tenacity to surprise with even 16% plus dollar revenue growth on the back of decent margins and...

"The margins for the bank, have remained around the same levels. On the asset quality side, definitely the bank has done well."

"One should not discard TCS because of the numbers being at their all-time highs. It has always a probability of surprising you positively ...

Mangesh Bhadang, Cement Research Analyst, Institutional Equities, Quant Broking Pvt. Ltd, gives his views on UltraTech Cement.

"UltraTech numbers were way below estimates. The results has emphasised the ground realities which the stock seems to have forgotten."

In an interview with ET Now, Basudeb Banerjee, Research Analyst, Quant Broking Pvt Ltd, shares his outlook on HCL’s latest numbers.

BHEL plunged as much as 11.6% to hit its 52-week low of Rs 132, after the power equipment maker posted nearly 50% decline in net profit.

"In Ambuja we are looking for a flat top line of around Rs 2500 crore and expect the PAT to be 26-27% down to around Rs 340 crore. "

"Big players like Michelin, Goodyear, all are planning to invest in US tyre market. So I would not say that times are bad for Cooper Tire."

Shares of IDFC gained momentum in trade on Tuesday as sentiment turned bullish on expectations that it may get a banking licence.

L&T Finance, Shriram Transport, LIC Housing and the other corporate houses like ABNL have a very high chance of getting a banking licence.

In terms of leadership and strategies, some of the experiences of Mr Narayana Murthy will surely matter in the longer run.

"Hero MotoCorp has come out with a good set of numbers after disappointing for past several quarters."

After rallying over 10 per cent so far in April, analysts say there is more upside seen in the stock from current levels.

The long-term investors who like stable business and sustainable recurring set of numbers will prefer TCS.

In an interview with ET Now, Shardul Pradhan, Research Analyst, Quant Broking Pvt Ltd, gives his take on Sun Pharma’s Q2 numbers.Excerpts: